Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.

Launched by IRCCS SAN RAFFAELE · Dec 11, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the experiences of patients who have undergone a specific type of surgery called TURBK, which is used to remove bladder cancer. The goal is to understand how often patients might have a return of cancer (relapses) and how their quality of life is affected after the surgery. Researchers will collect information about adult patients who have had this procedure, as well as other similar surgeries, to learn more about their recovery and wellbeing.

To participate in this trial, you need to be at least 18 years old and have been diagnosed with non-muscle invasive bladder cancer, which means the cancer has not spread deeply into the bladder wall. You'll also need to be capable of reading and signing a consent form to agree to be part of the study. If you join, you can expect to provide information about your health after surgery, which will help doctors understand better how to care for patients with bladder cancer in the future. This study is currently looking for participants, and both men and women are welcome to join.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 18 years or older
• • Patients with non-muscle invasive bladder cancer
• • Indication to cancer removal through endoscopic resection surgery
• • Ability to read and sign the informed consent
• Exclusion Criteria:
• • Age \<18 years
• • Inability to read and sign the informed consent